S&P 500   3,776.83 (-0.49%)
DOW   30,887.81 (-0.33%)
QQQ   312.84 (-0.48%)
AAPL   128.45 (-0.36%)
MSFT   213.30 (+0.13%)
FB   252.83 (+2.93%)
GOOGL   1,736.74 (+0.34%)
AMZN   3,112.57 (-0.48%)
TSLA   838.13 (-0.81%)
NVDA   520.14 (-1.49%)
BABA   244.41 (+0.59%)
CGC   33.42 (-3.47%)
GE   11.49 (-1.46%)
MU   80.80 (-0.62%)
AMD   89.54 (-1.38%)
T   29.14 (-0.51%)
NIO   57.20 (-6.03%)
F   9.88 (-2.85%)
ACB   12.14 (+1.51%)
BA   206.05 (-1.84%)
DIS   171.42 (-1.16%)
NFLX   503.22 (+0.47%)
GILD   63.42 (+1.63%)
S&P 500   3,776.83 (-0.49%)
DOW   30,887.81 (-0.33%)
QQQ   312.84 (-0.48%)
AAPL   128.45 (-0.36%)
MSFT   213.30 (+0.13%)
FB   252.83 (+2.93%)
GOOGL   1,736.74 (+0.34%)
AMZN   3,112.57 (-0.48%)
TSLA   838.13 (-0.81%)
NVDA   520.14 (-1.49%)
BABA   244.41 (+0.59%)
CGC   33.42 (-3.47%)
GE   11.49 (-1.46%)
MU   80.80 (-0.62%)
AMD   89.54 (-1.38%)
T   29.14 (-0.51%)
NIO   57.20 (-6.03%)
F   9.88 (-2.85%)
ACB   12.14 (+1.51%)
BA   206.05 (-1.84%)
DIS   171.42 (-1.16%)
NFLX   503.22 (+0.47%)
GILD   63.42 (+1.63%)
S&P 500   3,776.83 (-0.49%)
DOW   30,887.81 (-0.33%)
QQQ   312.84 (-0.48%)
AAPL   128.45 (-0.36%)
MSFT   213.30 (+0.13%)
FB   252.83 (+2.93%)
GOOGL   1,736.74 (+0.34%)
AMZN   3,112.57 (-0.48%)
TSLA   838.13 (-0.81%)
NVDA   520.14 (-1.49%)
BABA   244.41 (+0.59%)
CGC   33.42 (-3.47%)
GE   11.49 (-1.46%)
MU   80.80 (-0.62%)
AMD   89.54 (-1.38%)
T   29.14 (-0.51%)
NIO   57.20 (-6.03%)
F   9.88 (-2.85%)
ACB   12.14 (+1.51%)
BA   206.05 (-1.84%)
DIS   171.42 (-1.16%)
NFLX   503.22 (+0.47%)
GILD   63.42 (+1.63%)
S&P 500   3,776.83 (-0.49%)
DOW   30,887.81 (-0.33%)
QQQ   312.84 (-0.48%)
AAPL   128.45 (-0.36%)
MSFT   213.30 (+0.13%)
FB   252.83 (+2.93%)
GOOGL   1,736.74 (+0.34%)
AMZN   3,112.57 (-0.48%)
TSLA   838.13 (-0.81%)
NVDA   520.14 (-1.49%)
BABA   244.41 (+0.59%)
CGC   33.42 (-3.47%)
GE   11.49 (-1.46%)
MU   80.80 (-0.62%)
AMD   89.54 (-1.38%)
T   29.14 (-0.51%)
NIO   57.20 (-6.03%)
F   9.88 (-2.85%)
ACB   12.14 (+1.51%)
BA   206.05 (-1.84%)
DIS   171.42 (-1.16%)
NFLX   503.22 (+0.47%)
GILD   63.42 (+1.63%)
Log in
NASDAQ:LNTH

Lantheus Short Interest Ratio and Short Volume

$15.60
-0.31 (-1.95 %)
(As of 01/15/2021 12:20 PM ET)
Add
Compare
Today's Range
$15.46
Now: $15.60
$16.03
50-Day Range
$13.00
MA: $14.25
$15.77
52-Week Range
$8.67
Now: $15.60
$19.23
Volume4,865 shs
Average Volume549,895 shs
Market Capitalization$1.04 billion
P/E Ratio195.02
Dividend YieldN/A
Beta1.32

Short Interest

Lantheus (NASDAQ:LNTH) Short Interest Data

Current Short Volume:2,210,000 shares
Previous Short Volume:2,290,000 shares
Change Vs. Previous Month:-3.49%
Dollar Volume Sold Short:$32.91 million
Short Interest Ratio / Days to Cover:4.0
Last Record Date:December, 31 2020
Outstanding Shares:38,820,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:4,865 shares
Average Trading Volume:549,895 shares
Today's Volume Vs. Average:-99.12%



Lantheus (NASDAQ:LNTH) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
12/31/20202,210,000 $32.91 million -3.5%0.0%4.2$14.89
12/15/20202,210,000 $30.92 million -3.5%0.0%4.2$13.99
11/30/20202,290,000 $34.01 million 13.4%0.0%4.7$14.85
11/15/20202,020,000 $26.58 million 8.6%0.0%4.2$13.16
10/30/20201,860,000 $22.62 million -9.3%0.0%4.1$12.16
10/15/20202,050,000 $24.54 million 10.8%0.0%4.1$11.97
9/30/20201,850,000 $24.18 million -11.9%0.0%0$13.07
9/15/20202,100,000 $25.62 million 0.5%0.0%3.6$12.20
8/31/20202,090,000 $26.98 million 2.0%0.0%2.8$12.91
8/14/20202,050,000 $26.92 million -6.4%0.0%2.7$13.13
7/31/20202,190,000 $29.35 million -4.0%0.0%3$13.40
7/15/20202,280,000 $30.99 million -28.3%0.0%3.5$13.59
6/30/20203,180,000 $50.21 million 32.5%0.0%5.2$15.79
6/15/20202,400,000 $34.10 million 10.6%0.0%4.3$14.21
5/29/20202,170,000 $29.38 million -5.2%5.6%5.3$13.54
5/15/20202,290,000 $31.44 million -6.9%6.0%5.1$13.73
4/30/20202,460,000 $33.97 million -8.2%6.4%5.5$13.81
4/15/20202,680,000 $34.28 million 0.8%7.0%6$12.79
3/31/20202,660,000 $36.28 million 5.6%7.0%5.7$13.64
3/13/20202,518,600 $33.27 million 51.7%6.9%4.6$13.21
2/28/20201,660,000 $18.36 million 12.2%4.5%4$11.06
2/14/20201,480,000 $20.54 million -6.3%3.9%3.9$13.88
1/31/20201,580,000 $25.75 million 7.5%4.2%4.4$16.30
1/15/20201,470,000 $24.92 million 5.0%3.9%3.7$16.95
12/31/20191,400,000 $25.24 million 14.8%3.7%3.9$18.03

Lantheus (NASDAQ:LNTH) Short Interest FAQ

speech bubbles
speech bubbles











What is Lantheus' current short interest?

Short interest is the volume of Lantheus shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 2,210,000 shares of LNTH short. 0.00% of Lantheus' shares are currently sold short. View details.

What is a good short interest ratio for Lantheus?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Lantheus currently has a short interest ratio of 4.0.

Is Lantheus' short interest increasing or decreasing?

Lantheus saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 2,210,000 shares, a decline of 3.5% from the previous total of 2,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Lantheus' short interest compare to its competitors?

0.00% of Lantheus' shares are currently sold short. Here is how the short interest of companies in the industry of "diagnostic substances" compare to Lantheus: Riot Blockchain, Inc. (0.00%), Myriad Genetics, Inc. (13.40%), Heska Co. (0.00%), Meridian Bioscience, Inc. (8.75%), Celldex Therapeutics, Inc. (0.00%), Quotient Limited (0.00%), Oxford Immunotec Global PLC (1.58%), OncoCyte Co. (0.00%), Nymox Pharmaceutical Co. (9.21%), and Trinity Biotech plc (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short Lantheus stock?

Short selling LNTH is an investing strategy that aims to generate trading profit from Lantheus as its price is falling. Lantheus' stock is trading down $0.31 today. To short Lantheus stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Lantheus will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lantheus?

A short squeeze for Lantheus occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LNTH, which in turn drives the price of the stock up even further.

How often is Lantheus' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LNTH, twice per month. The most recent reporting period available is December, 31 2020.


This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.